share_log

Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month Low at $4.10

Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month Low at $4.10

凯莱布里特DI(纳斯达克:CLBT)跌至4.10美元,创12个月新低
Financial News Live ·  2022/09/22 18:52

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) shares hit a new 52-week low on Thursday . The stock traded as low as $4.10 and last traded at $4.14, with a volume of 24199 shares changing hands. The stock had previously closed at $4.28.

凯乐布莱特DI有限公司(纳斯达克代码:CLBT-GET Rating)的股价周四创下52周新低。该股一度跌至4.1美元,最新报4.14美元,成交量为24199股。该股此前收盘价为4.28美元。

Analysts Set New Price Targets

分析师设定新的价格目标

CLBT has been the subject of a number of research analyst reports. Needham & Company LLC lifted their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the stock a "buy" rating in a research report on Thursday, August 11th. William Blair downgraded shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Bank of America downgraded shares of Cellebrite DI from a "buy" rating to a "neutral" rating and cut their target price for the stock from $6.50 to $6.00 in a research report on Friday, August 12th. Cowen cut their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Finally, Cowen cut their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.

CLBT已成为多份研究分析师报告的主题。Needham&Company LLC在8月11日(星期四)的一份研究报告中将Cellebrite DI的目标价从6.00美元上调至6.50美元,并给予该股“买入”评级。在8月12日星期五的一份研究报告中,威廉·布莱尔将Cellebrite DI的股票评级从“跑赢大盘”下调至“市场表现”。在8月12日周五的一份研究报告中,美国银行将Cellebrite DI的股票评级从买入下调至中性,并将该股的目标价从6.50美元下调至6.00美元。考恩在8月12日(星期五)的一份研究报告中将Cellebrite DI的目标价从13.00美元下调至10.00美元,并为该公司设定了“跑赢大盘”的评级。最后,考恩将Cellebrite DI的目标价从13.00美元下调至10.00美元,并在8月12日(星期五)的一份研究报告中为该公司设定了“跑赢大盘”的评级。两名研究分析师对该股的评级为持有,六名分析师对该公司的评级为买入。根据MarketBeat的数据,该公司的普遍评级为“适度买入”,平均目标价为9.71美元。

Get
到达
Cellebrite DI
丝光沸石DI
alerts:
警报:

Cellebrite DI Trading Down 3.5 %

Cellebrite DI降价3.5%

The company has a market cap of $778.67 million, a PE ratio of 5.78, a PEG ratio of 9.96 and a beta of 0.87. The business's 50 day moving average is $5.04 and its two-hundred day moving average is $5.36.

该公司市值为7.7867亿美元,市盈率为5.78倍,聚乙二醇率为9.96倍,贝塔系数为0.87。该业务的50日移动均线切入位在5.04美元,200日移动均线切入位在5.36美元。

Institutional Trading of Cellebrite DI

凯勒布利特DI的机构交易

Several hedge funds have recently bought and sold shares of the stock. Phoenix Holdings Ltd. raised its position in shares of Cellebrite DI by 303.6% during the 1st quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock valued at $14,706,000 after buying an additional 1,727,379 shares in the last quarter. Greenhaven Road Investment Management L.P. purchased a new stake in shares of Cellebrite DI during the 4th quarter valued at about $9,453,000. Blair William & Co. IL raised its position in shares of Cellebrite DI by 3,021.1% during the 1st quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock valued at $3,353,000 after buying an additional 507,190 shares in the last quarter. ARK Investment Management LLC purchased a new stake in shares of Cellebrite DI during the 1st quarter valued at about $2,621,000. Finally, CIBC Asset Management Inc raised its position in shares of Cellebrite DI by 5.8% during the 1st quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock valued at $15,057,000 after buying an additional 129,244 shares in the last quarter. Hedge funds and other institutional investors own 20.41% of the company's stock.
几家对冲基金最近买卖了该股的股票。菲尼克斯控股有限公司在第一季度将其在Cellebrite DI的股票头寸提高了303.6%。凤凰卫视控股有限公司目前持有该公司2,296,345股股票,价值14,706,000美元,该公司在上个季度又购买了1,727,379股。Greenaven Road Investment Management L.P.在第四季度购买了Cellebrite DI的新股,价值约9,453,000美元。Blair William&Co.IL在第一季度将其在Cellebrite DI的股票头寸增加了3021.1%。Blair William&Co.IL现在持有523,978股该公司股票,价值3,353,000美元,上个季度又购买了507,190股。方舟投资管理有限责任公司在第一季度购买了Cellebrite DI的新股份,价值约2,621,000美元。最后,加拿大帝国商业银行资产管理公司在第一季度将其在Cellebrite DI的股票头寸提高了5.8%。加拿大帝国商业银行资产管理公司(CIBC Asset Management Inc.)目前持有该公司2,352,733股股票,价值15,057,000美元,上一季度又购买了129,244股。对冲基金和其他机构投资者持有该公司20.41%的股份。

About Cellebrite DI

关于Cellebrite DI

(Get Rating)

(获取评级)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.

Cellebrite DI Ltd.为法律批准的调查开发解决方案。其DI平台允许用户在整个调查生命周期中收集、审查、分析和管理与法律批准的调查有关的数字数据,并在各种案件中使用解决方案,包括剥削儿童、凶杀、反恐、边境控制、性犯罪、人口贩运、企业安全、知识产权盗窃和民事诉讼。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免费获取StockNews.com关于Cellebrite DI(CLBT)的研究报告
  • 这些机构持有达顿餐饮国际公司的股份
  • 斯蒂尔凯斯的收益说明了他重返办公室的原因吗?
  • 住房建设的黄金时代已经结束了吗?
  • 这三大股利支付者也拥有强劲的价格增长
  • 天然气价格继续回升,这些股票应该会受益

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.

接受《凯尔布赖特DI日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cellebrite DI和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发